Recent Advances in Taeniasis and Cysticercosis
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Parasitic Pathogens".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 26785
Special Issue Editors
2. Center for Global Health, University Peruana Cayetano Heredia, Lima, Peru
Interests: parasitic disease of the nervous system; cysticercosis and neurocysticercosis; cystic echinococcosis
Interests: infectious diseases; expertise in parasitology
2. NIHR University College London Hospitals Biomedical Research Centre, UCL Queen Square Institute of Neurology, London, UK
Interests: neurology; survival in neurocysticercosis
Special Issue Information
Dear Colleagues,
Taenia solium is still endemic in most of the developing world. Neurocysticercosis (NCC), the invasion of the human central nervous system by its larval stage or cysticercus, is a major cause of seizures and epilepsy in endemic regions, where it accounts for approximately 30% of cases. While the clinical expression of NCC has been studied for many years, its pathogenesis is not well-understood, in particular the mechanisms leading to brain inflammation, brain damage and epileptogenesis. This Special Issue will collate articles on epidemiology/control, pathogenesis, clinical expression, diagnosis, and the treatment of human and animal neurocysticercosis to provide readers with an updated body of information that reflects the advances made in this field of research over the past decades.
Prof. Dr. Hector H. Garcia
Prof. Dr. Christina M. Coyle
Prof. Dr. Gagandeep Singh
Prof. Dr. Oscar H. Del Brutto
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Taenia solium
- taeniasis
- cysticercosis
- neurocysticercosis
- epilepsy
- nervous system
- central nervous system
- diagnostics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.